Delivery Order SPE2DR25D3103-SPE2DR26F9N99
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,817.44 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price, non-set-aside delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $50,306.61 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This non-competitive delivery order, which is scheduled for completion by August 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $32,178.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside award was issued from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,654.32 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of December 11, 2025. The contract carries no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $39,150.40 to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count). This competitively awarded, firm fixed-price contract is set to be completed by November 19, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $1,089.41. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement process. The order is set to reach completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp was awarded a $6,447.64 firm fixed-price delivery order by the Defense Logistics Agency on November 25, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination inhaler medication for chronic obstructive pulmonary disease treatment). The order, which is expected to be completed by November 26, 2025, carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing contract vehicle. The place of performance is listed as...
- The Defense Logistics Agency awarded a $13,678.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) valued at $101,693.21. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Trelegy...
- The Defense Logistics Agency awarded a delivery order valued at $13,758.08 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count supply) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9N99Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $37,759.81 by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count package). This is a firm fixed-price, non-competitive set-aside delivery order with a completion date of December 12, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The Trelegy Ellipta being procured under this delivery order is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease, reflecting the DLA's ongoing need for specialty medications to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.8k | 12/10/25 |